Holen Sie sich die Stockscreener-App
6.10
2.86%
-0.19
Handel nachbörslich:
6.10
Schlusskurs vom Vortag:
$6.29
Offen:
$6.13
24-Stunden-Volumen:
30,743
Relative Volume:
0.32
Marktkapitalisierung:
$236.16M
Einnahmen:
$4.71M
Nettoeinkommen (Verlust:
$-46.77M
KGV:
-3.6327
EPS:
-1.6792
Netto-Cashflow:
$-60.34M
1W Leistung:
-6.29%
1M Leistung:
+16.60%
6M Leistung:
+2.17%
1J Leistung:
-35.68%
1-Tages-Spanne:
$6.045
$6.1728
1-Wochen-Bereich:
$5.9714
$6.8745
52-Wochen-Spanne:
$4.345
$11.87
Nyxoah Sa Stock (NYXH) Company Profile
Vergleichen Sie NYXH mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NYXH
Nyxoah Sa
|
6.10 | 236.16M | 4.71M | -46.77M | -60.34M | -1.6792 |
|
ISRG
Intuitive Surgical Inc
|
436.39 | 156.20B | 9.15B | 2.63B | 1.99B | 7.1661 |
|
BDX
Becton Dickinson Co
|
188.35 | 53.50B | 21.39B | 1.61B | 2.55B | 5.5609 |
|
RMD
Resmed Inc
|
270.15 | 39.84B | 5.15B | 1.40B | 1.65B | 9.5082 |
|
ALC
Alcon Inc
|
74.08 | 35.89B | 10.03B | 1.07B | 1.39B | 2.1549 |
|
WST
West Pharmaceutical Services Inc
|
261.26 | 18.87B | 2.96B | 487.70M | 344.00M | 6.6758 |
Nyxoah Sa Stock (NYXH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-07-31 | Eingeleitet | H.C. Wainwright | Buy |
| 2023-07-19 | Eingeleitet | Robert W. Baird | Neutral |
| 2022-04-21 | Eingeleitet | Oppenheimer | Outperform |
| 2022-04-06 | Eingeleitet | Wolfe Research | Peer Perform |
| 2021-12-21 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2021-07-28 | Eingeleitet | Cantor Fitzgerald | Overweight |
Alle ansehen
Nyxoah Sa Aktie (NYXH) Neueste Nachrichten
Will Nyxoah SA stock go up soonWeekly Profit Report & AI Powered Buy/Sell Recommendations - newser.com
Chart based analysis of Nyxoah SA trendsJuly 2025 Summary & Daily Technical Stock Forecast Reports - newser.com
Nyxoah's (NYXH) "Sell (D-)" Rating Reiterated at Weiss Ratings - MarketBeat
How Nyxoah SA (5YI) stock behaves under inflation pressure2025 Market Trends & AI Forecasted Entry and Exit Points - newser.com
Intraday pattern recognizer results for Nyxoah SAMarket Trend Review & Safe Capital Preservation Plans - newser.com
What is the fair value estimate for Nyxoah SA (5YI) stock in 2025Portfolio Performance Summary & Real-Time Sentiment Analysis - newser.com
Nyxoah SA Stock Analysis and ForecastShort Selling Opportunities & Market Trend Real-Time Reports - earlytimes.in
Applying big data sentiment scoring on Nyxoah SA2025 Macro Impact & Low Risk Entry Point Tips - newser.com
Exit strategy if you’re trapped in Nyxoah SA2025 Geopolitical Influence & Daily Risk Controlled Trade Plans - newser.com
How to manage a losing position in Nyxoah SAWeekly Investment Summary & High Conviction Buy Zone Alerts - newser.com
Is Nyxoah SA (5YI) stock suitable for passive index funds2025 Key Highlights & Weekly Setup with ROI Potential - newser.com
Nyxoah Shares Rise on First U.S. Commercial Use of Genio System - sharewise.com
Nyxoah Announces First U.S. Commercial Patients Implanted with Genio® System - Sahm
Nyxoah stock surges after first commercial US implants - Investing.com
US-Listed Nyxoah Shares Soar On First Genio System Implants In Patients With Sleep Disorder - Stocktwits
First U.S. Genio® commercial implants — Nyxoah gains CMS coverage, surgeon training and VAC approvals - Stock Titan
Nyxoah Expands in the Middle East to Provide Wider Access to Genio - MSN
Publication relating to transparency notifications - GlobeNewswire
What analysts say about Nyxoah SA stockVolume Weighted Average Price & Beat the Market with AI Reports - earlytimes.in
Nyxoah SA 5YI Stock Analysis and ForecastStock Valuation Metrics & Low Cost Wealth Investment - earlytimes.in
Is Nyxoah SA a good long term investmentRetail Trading Trends & What the Pros Are Saying About This Stock - earlytimes.in
What analysts say about Beijer Alma AB publ 6O4 stockBreakout Stock Watch & Register for the Next Free Workshop - earlytimes.in
Does Nyxoah's Patent Lawsuit Alter the Bull Case for Inspire Medical Systems (INSP)? - simplywall.st
Nyxoah Expands Middle East Presence with New Centers - TipRanks
Nyxoah expands neuromod for sleep apnea to Middle East - MassDevice
Nyxoah Enters Underwriting Agreement for Public Offering - TipRanks
Nyxoah Provides an Update on Expanded Middle East Presence - GlobeNewswire
Revolutionary Sleep Apnea Treatment: Nyxoah's Genio System Expands Across Middle East Healthcare Hubs - Stock Titan
Nyxoah Leads The Charge In European Penny Stocks - simplywall.st
Rally Mode: Is now the right time to enter Nyxoah SAQuarterly Portfolio Review & AI Optimized Trading Strategy Guides - خودرو بانک
Bank Watch: Does Nyxoah SA have a competitive edgeJuly 2025 Recap & Detailed Earnings Play Strategies - خودرو بانک
Geopolitics Watch: Will Nyxoah SA outperform during market ralliesWeekly Stock Report & Technical Buy Zone Confirmations - خودرو بانک
Will Nyxoah SA continue its uptrendJuly 2025 Patterns & Fast Entry High Yield Tips - newser.com
Understanding Nyxoah SA’s price movement2025 Volatility Report & AI Powered Buy/Sell Recommendations - newser.com
Trend analysis for Nyxoah SA this weekWeekly Trend Summary & Low Risk High Win Rate Stock Picks - newser.com
Winners Losers: Is Nyxoah SA stock undervalued right nowBreakout Watch & Verified Momentum Watchlists - khodrobank.com
Aug Swings: Will Nyxoah SA outperform during market rallies2025 Performance Recap & Expert Curated Trade Setup Alerts - khodrobank.com
Finanzdaten der Nyxoah Sa-Aktie (NYXH)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.91%
0.48%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):